NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EyeYon Medical

EyeYon Medical

Private
Ness ZionaHealthcare & Life Scienceshttps://eye-yon.com/

Last Round

Series C

Mar 15, 2021

Total Funding Raised

$35.8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

EyeYon Medical is a medical device company that develops innovative ophthalmic technologies, including synthetic corneal implants and therapeutic contact lenses, to treat corneal edema and endothelial dysfunction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

corneal implantcorneal edemaophthalmic devicesynthetic corneatherapeutic contact lenscorneal surgerycorneal endothelial dysfunctionbiocompatible implantartificial corneakeratoprosthesiscorneal transplant alternativeophthalmology medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EyeYon Medical Comps

Public and private peers based on sector, stage, and business model.

EyeYon Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EyeYon Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 15, 2021
Series BMar 21, 2017
Series AApr 21, 2015

Key People

Founding team and executive leadership

Nahum Ferera

CEO & Co Founder

Founding Team

Dmitry Dubson

Chief Technology Officer

Executive Team

Ethan Nash

Chief Financial Officer

Executive Team

EyeYon Medical Investors

Notable investors and investment history

EyeYon Medical investors
InvestorRounds
Diamond BioFundSeries C
Israel Innovation AuthoritySeries A, Series B
Pontifax Venture CapitalSeries A, Series C, Series B
Docor International ManagementSeries A
BPCSeries C
Quark Venture LPSeries C
RimonciSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors increased 52% MoM.

  • Apr 15, 2026

    Monthly visitors grew 64% MoM, reaching 1.7K.

EyeYon Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EyeYon Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EyeYon Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersNess Ziona
Employee Range27
Year Founded2011
Last FundingMar 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.